Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-30FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's methylphenidate hydrochloride under an ANDA, adjusting the regulatory status…
-
FDA approval · 2024-08-30FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Methylphenidate Hydrochloride Extended-Release from SpecGx LLC.
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for dexmethylphenidate hydrochloride manufactured by Teva Pharmaceuticals USA, Inc. (a generic A…
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic dexmethylphenidate hydrochloride product from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2024-08-21FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for a generic dexmethylphenidate hydrochloride product, expanding ADHD treatment options.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-08-16FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Actavis Pharma, Inc., updating the product under an ANDA.
-
FDA approval · 2024-07-26FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original generic application for lisdexamfetamine dimesylate, authorizing its use as a stimulant medication. T…
-
FDA approval · 2024-06-28FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
The FDA approved a supplemental ANDA for a generic Dexmethylphenidate Hydrochloride product from Cranbury Pharmaceuticals, enabling market e…
-
FDA approval · 2024-06-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a Supplemental Application from Sandoz Inc for a generic combination product containing dextroamphetamine saccharate, amphetami…
-
FDA approval · 2024-06-12FDA Approved: GUANFACINE — Original Application (Fosun Pharma USA, Inc)
FDA approved the original application for guanfacine from Fosun Pharma USA, Inc, providing a generic version of guanfacine.
-
FDA approval · 2024-06-06FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Mayne Pharma Commercial LLC)
FDA approved a supplemental application for methamphetamine hydrochloride from Mayne Pharma Commercial LLC.
-
FDA approval · 2024-06-04FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Solco Healthcare US,LLC)
FDA approved a supplemental application for lisdexamfetamine dimesylate capsules submitted by Solco Healthcare US, LLC. The approval covers …
-
FDA approval · 2024-06-03FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
The FDA approved a supplemental application for methylphenidate hydrochloride from KVK-Tech, Inc., authorizing their generic product under a…
-
FDA approval · 2024-05-30FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic formulation containing four amphetamine salt components (dextroamphetamine saccharate,…
-
FDA approval · 2024-05-24FDA Approved: ONYDA XR — Original Application (NextWave Pharmaceuticals, Inc)
FDA approved ONYDA XR (clonidine hydrochloride) from NextWave Pharmaceuticals as a new extended-release treatment for attention-deficit/hype…
-
FDA approval · 2024-05-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA granted a supplemental approval for methylphenidate hydrochloride from Cranbury Pharmaceuticals, LLC, updating the approved generic prod…
-
FDA approval · 2024-04-18FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methamphetamine hydrochloride (Hikma Pharmaceuticals USA Inc.).
-
FDA approval · 2024-04-11FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for methylphenidate hydrochloride from Dr. Reddy's Laboratories Inc, updating the approval for the g…
-
FDA approval · 2024-04-10FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Northstar Rx LLC)
The FDA approved a supplemental application for methylphenidate hydrochloride from Northstar Rx LLC, authorizing the generic product. Methyl…
-
FDA approval · 2024-04-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for methylphenidate hydrochloride (LA) from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2024-04-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride.
-
FDA approval · 2024-04-01FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved Elite Laboratories, Inc.'s supplemental application for a fixed combination of amphetamine salts (dextroamphetamine sacchar…
-
FDA approval · 2024-04-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Neolpharma, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride from Neolpharma, Inc. under ANDA208737, granting approval for this…
-
FDA approval · 2024-04-01FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for a generic mixed amphetamine salts extended-release product (dextroamphetamine…
-
FDA approval · 2024-03-28FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic product containing four amphetamine salt components, manufactured by Sun Pharmaceu…